Live Breaking News & Updates on Secondary End Points

Stay updated with breaking news from Secondary end points. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial | Diabetes | JAMA

Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial | Diabetes | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

Eli Lilly , Xiaoying Li , Department Of Endocrinology , Fudan University , Among Chinese , Secondary End Points , Zhongshan Hospital , Xuhui District , Drs Wang , Interest Disclosures ,

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

This phase 2 randomized trial examines the antihypertensive efficacy and safety of different zilebesiran dosing regimens. ....

United States , United Kingdom , University Of Chicago , Eteläuomen Läi , Eli Lilly , Vifor Pharma , Pharmagenesis Cardiff , Georgel Bakris , Boehringer Ingelheim , American Heart Association Comprehensive Hypertension Center , Novo Nordisk , International Conference On Harmonization , Department Of Medicine , American Heart Association Scientific Sessions , Study Group , Group Information , University Of Chicago Medicine , Recor Medical Inc , Alnylam Pharmaceuticals , Ablative Solutions Inc , Good Clinical Practice , International Conference , Renal Disease , Medical Dictionary , Regulatory Activities , End Point ,

Tiragolumab Plus Atezolizumab and Chemotherapy Offers Survival Benefit Over Chemotherapy Alone in ESCC

Tiragolumab plus atezolizumab and chemotherapy led to significant survival improvements vs chemotherapy in patients with esophageal squamous cell carcinoma. ....

South Korea , Hong Kong , Baseline Patient , Secondary End Points , 2024 Gastrointestinal Cancers Symposium , Asco Gi , Esophageal Squamous Cell Carcinoma , Skyscraper 08 ,

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial | Cardiology | JAMA

This randomized clinical trial examines the effect of tirzepatide on the maintenance of weight reduction. ....

Eteläuomen Läi , New York , United States , United Kingdom , Louisj Aronne , Senda Biosciences , Medtech Epitomee , Eli Lilly , Bausch Health Canada , Group Information , Boehringer Ingelheim , Novo Nordisk , Health Survey , Abbott Laboratories , Weight Control Center , European Association For Study Of Diabetes , Division Of Endocrinology , Hanmi Pharmaceuticals , International Organizations , Medical Sciences International Ethical Guidelines , Good Clinical Practice , Life Lite Clinical Trials Version , Size Calculation , Label Lead In Period , Blind Period , End Point ,

Janssen's Personalized Approach To Depressive Disorder Patients

Janssen's Personalized Approach To Depressive Disorder Patients
clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.

Janssen Neurosciencedrevets , Wayne Drevets , Ed Miseta , Chief Editor , Secondary End Points , Montgomery Asberg Depression Rating Scale , Hamilton Depression Rating , Hamilton Depression Rating Scale ,